-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

Benzinga·07/13/2026 09:59:47
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $70 to $77.